Filter posts

Biopharma Takes Aim at Opioid Abuse

Next-generation painkillers in development are non-addictive One in three Americans – roughly 100 million people …

Coming Down the Pipeline: Patent Cases to Watch in 2017

The Supreme Court returns from recess on February 17, and alongside the likely confirmation of …

Curing Cancer: Advancements and What is Yet to Come

  Last month, MIT Technology Review reported “Two Infants Treated with Universal Immune Cells Have …

BIO Officially Opens Registration for the 2017 World Congress on Industrial Biotechnology

We are  pleased to announce BIO’s World Congress on Industrial Biotechnology is the world’s largest …

Best Practices for Communication Between FDA and IND Sponsors During Drug Development

The FDA recently released an online course to provide insights to drug sponsors on communicating …

Huff Post: We’re Asking The Wrong Questions About GMOs

The scientific community has reached a consensus: It’s generally safe for genetically-modified organisms to be in …